🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: * To determine the safety of adback T- or Natural Kille...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2007-09
Trial ID
NCT00536978
This phase I trial studies the safety of transplantation with a haploidenti...
Status
Recruiting
Location
University of Wisconsin Carbone Cancer Center
Start Date
2016-02-12
Trial ID
NCT02508038
Treatments Being Tested
This is a randomized phase II trial of standard-of-care reduced-intensity c...
Status
Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2025-03-27
Trial ID
NCT06803745
Treatments Being Tested
The study hypotheses is that the introduction of dose escalated treosulfan,...
Status
Completed
Location
Chaim Sheba Medical Center
Start Date
2007-06
Trial ID
NCT00491634
Treatments Being Tested
To elucidate the longitudinal development of intestinal microbiota in patie...
Status
Terminated
Location
Children's hospital of Fudan university
Start Date
2017-10-01
Trial ID
NCT03752372
Treatments Being Tested
This study aims to investigate a novel therapeutic strategy of integrated r...
Status
Recruiting
Location
the First Affiliated Hospital of Soochow University
Start Date
2024-12-10
Trial ID
NCT07059741
Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive and fatal neur...
Status
Enrolling By Invitation
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2025-12-29
Trial ID
NCT07539662
Treatments Being Tested
The primary goal of this study by The Polish Adult Leukemia Group (PALG) is...
Status
Unknown
Location
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch
Start Date
2012-08
Trial ID
NCT01665001
Treatments Being Tested
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested
This phase II trial studies how well giving a JAK inhibitor before a donor ...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2014-10-20
Trial ID
NCT02251821